Straits Times Index
3,350.73 +14.14 (+0.42%) Nikkei
38,951.46 +463.56 (+1.20%) Hang Seng
18,498.33 +418.72 (+2.32%) FTSE 100
8,275.38 +44.33 (+0.54%) Bitcoin USD
68,420.20 +610.43 (+0.90%) CMC Crypto 200
1,478.93 +50.36 (+3.52%)
NovaBay Pharmaceuticals, Inc. (NBY)
After hours:
| Previous close | 3.6470 |
| Open | 3.3500 |
| Bid | 0.0000 x 900 |
| Ask | 0.0000 x 1200 |
| Day's range | 3.0800 - 3.5500 |
| 52-week range | 2.4500 - 44.8000 |
| Volume | |
| Avg. volume | 275,953 |
| Market cap | 3.718M |
| Beta (5Y monthly) | 2.04 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -120.4000 |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.68 |
- Business Wire
NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates
EMERYVILLE, Calif., May 29, 2024--NovaBay® Pharmaceuticals, Inc. the "Company") (NYSE American: NBY) announces that a quorum was reached and that all proposals in the Company’s Definitive Proxy Statement filed on April 18, 2024 with the Securities and Exchange Commission (the "SEC") were approved by stockholders at its 2024 Annual Meeting of Stockholders held on May 28, 2024. Among the proposals, stockholders approved a reverse stock split and authorized the Company’s Board of Directors to deter
Insider MonkeyNovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q1 2024 Earnings Call Transcript
NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q1 2024 Earnings Call Transcript May 11, 2024 NovaBay Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, welcome to the NovaBay Pharmaceuticals Financial Results Conference Call. At this time, all participants […]
- Business Wire
NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms
EMERYVILLE, Calif., May 13, 2024--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare and wound care products, announces the introduction of an expanded line of Avenova® product bundles specifically designed to provide easy, affordable and effective solutions for individualized relief from dry eye symptoms. The new Avenova product bundles align with findings among optometrists surveyed in the Eyes on Eyecare 2024 Dry Eye Report of th
